Also trades as: GTBP.PA (PAR)
GTBP NASDAQ
GT Biopharma, Inc.
1W: -12.3%
1M: -14.6%
3M: -50.7%
YTD: -70.4%
1Y: -62.8%
3Y: -96.8%
5Y: -99.9%
$6.10
-0.10 (-1.61%)
Weekly Expected Move ±32.3%
$2
$4
$6
$8
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
12 relationships12
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2022-08-30
Earliest Filing
2025-06-11
Latest Filing
investor: 5
target: 3
partner: 2
acquirer: 1
supplier: 1
Counterparties (Filed by GTBP)
12 relationshipsCompanies named in GTBP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| GT Biopharma, Inc. | GTBP | target | Company issuing shares in the purchase agreement | 2025-06-11 | View |
| Five Narrow Lane, L.P. | — | investor | Investor purchasing common shares | 2025-06-11 | View |
| Bristol Capital, LLC | — | investor | Investor purchasing common shares | 2025-06-11 | View |
| GT Biopharma, Inc. | GTBP | target | Company issuing Preferred Stock and Warrants in a securities purchase agreement amendment | 2025-05-27 | View |
| Five Narrow Lane, L.P. | — | investor | Initial purchaser and majority purchaser of Preferred Stock | 2025-05-27 | View |
| Bristol Capital LLC | — | investor | Initial purchaser and majority purchaser of Preferred Stock | 2025-05-27 | View |
| Robert A. Marzilli | — | investor | New party joining the securities purchase agreement as a purchaser | 2025-05-27 | View |
| Regents of the University of Minnesota | — | partner | Academic institution partnering with GT Biopharma for a clinical trial | 2024-11-21 | View |
| GT Biopharma, Inc. | GTBP | partner | Biopharmaceutical company partnering with University of Minnesota for a clinical trial | 2024-11-21 | View |
| GT Biopharma, Inc. | GTBP | acquirer | Acquirer entering into a settlement and investment agreement amendment | 2024-04-30 | View |
| Cytovance Biologics, Inc. | — | target | Target company receiving shares under the settlement and investment agreement | 2024-04-30 | View |
| Cytovance Biologics, Inc. | — | supplier | Agreement to modify payment terms for services related to GTB-3650 and GTB-5550 IND filings | 2022-08-30 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-25 | Other Events; Exhibits | View | |
| 2026-09-21 | Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits | Agreement | View |
| 2026-09-15 | Material Agreement; Unregistered Equity Sales; Bylaws Amendment; Exhibits | Agreement | View |
| 2026-09-03 | Bylaws Amendment; Other Events; Exhibits | View | |
| 2026-08-14 | Shareholder Vote; Exhibits | View | |
| 2026-06-12 | Bylaws Amendment; Exhibits | View | |
| 2026-05-22 | Delisting Notice; Exhibits | View | |
| 2026-04-07 | Material Agreement; Exhibits | Agreement | View |
| 2026-03-02 | Non-Reliance on Previously Issued Financial Statements; Financial Statements and Exhibits | View | |
| 2025-11-26 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-26 | Material Modification to Rights of Security Holders; Financial Statements and Exhibits | View | |
| 2025-09-23 | Material Modification to Rights of Security Holders; Financial Statements and Exhibits | View | |
| 2025-08-29 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-07-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-11 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-05-27 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-05-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifica | Agreement | View |
| 2025-05-13 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-05-05 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR